NEW SOLUTIONS
Financing solutions emerging from the market: A FoCUS survey and analysis
How are market leaders responding to the barriers of cost and uncertainty associated with cell and gene therapies to facilitate patient access and sustainable reimbursement? Our research finds a wide range of products are already available in the market that provide diverse approaches in various stages of maturity—but also that stakeholders may not yet be motivated to move away from individually negotiated arrangements. Get the white paper to learn what market solutions may become more popular, and why shifts toward particular solutions may appear.
Related
Jane Barlow and Michelle Harika present “Addressing Gene Therapy Financial Challenges: A survey of emerging market solutions” at the AMCP Nexus 2021 in Denver on October 18.
ONLINE RESOURCES
Paying for Cures: Actions self-insured employers can take today
In this panel discussion in the Self-Insured Employers Workshop, Mark Trusheim, Michelle Harika, Mehb Khoja, Cynthia Pigg, and Luke Prettol discuss practical steps to make cell and gene therapies accessible to their employees today.
See the discussion
IN THE COMMUNITY AND MEDIA
Mark Trusheim participated in the ASCGT Policy Forum panel “The Status of Medicaid Coverage and Access for Gene and Cell Therapies” on September 22, and on September 28 he led the roundtable “Preparing for 2022 regulatory change and the performance-based contracting explosion” for the Reuters Cell and Gene Therapy USA meeting. On September 30 Mark spoke in the OHE Master Class Adaptive Pathways: Generating Evidence of Value. He was interviewed for “Reality Check? Medicaid Costs From Cell, Gene Therapies Projected At (Just) $1Bn-$4Bn By 2030” in Pink Sheet on October 4. Mark also participated in the Advanced Regenerative Manufacturing Institute fall meeting on October 7, presenting FoCUS’s reimbursement research. On October 22 he participated in the McKinsey CGT Roundtable and the APEC Finance Ministers’ Meeting on October 28.
Jane Barlow participated in the 2021 Alliance for Innovation in Integrated Healthcare (AIIH) Summit, in the session entitled, “Impact of Cell and Gene Therapy” on October 11. Jane and Brendan Hayes will participate in the Great Lakes Hemophilia Foundation’s Comprehensive Gene Therapy Symposium on November 30.
Casey Quinn will participate in the HTX Expert Forum on November 25.
SAVE THE DATE
The next FoCUS Design Lab will be held on April 13–14, 2022. By invitation only.